We are live on ! Find out more
ATRS

Antares Pharma, Inc.
ATRS

Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

89 hedge funds and large institutions have $223M invested in Antares Pharma, Inc. in 2013 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 33 increasing their positions, 24 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more call options, than puts

Call options by funds: $947K | Put options by funds: $550K

38% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 24

30% more capital invested

Capital invested by funds: $171M → $223M (+$52M)

8% less funds holding

Funds holding: 97 → 89 (-8)

38% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 21

Holders
89
Holders Change
-8
Holders Change %
-8.25%
% of All Funds
2.58%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
13
Increased
33
Reduced
24
Closed
21
Calls
$947K
Puts
$550K
Net Calls
+$397K
Net Calls Change
-$243K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$8.6M
2
DM
Deerfield Management
New York
+$6.06M
3
KCM
Kingdon Capital Management
New York
+$5.01M
4
BC
Broadfin Capital
New York
+$3.26M
5
ACM
Ashford Capital Management
Delaware
+$2.73M

Top Sellers

Rank Fund Capital Flow
1
TAM
THB Asset Management
Connecticut
-$958K
2
BFA
BlackRock Fund Advisors
California
-$467K
3
Deutsche Bank
Deutsche Bank
Germany
-$466K
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$328K
5
Morgan Stanley
Morgan Stanley
New York
-$311K
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$45.3M +$6.06M +1,488,055 +17%
O
2
OrbiMed
New York
$20.5M +$925K +227,000 +5%
BIT
3
BlackRock Institutional Trust
California
$17M +$406K +99,572 +3%
Vanguard Group
4
Vanguard Group
Pennsylvania
$15.9M +$640K +156,972 +5%
BFA
5
BlackRock Fund Advisors
California
$13.8M -$467K -114,635 -4%
Millennium Management
6
Millennium Management
New York
$9.58M +$8.6M +2,109,567 +6,235%
State Street
7
State Street
Massachusetts
$8.95M +$185K +45,324 +2%
KCM
8
Kingdon Capital Management
New York
$8.06M +$5.01M +1,229,100 +214%
WHI
9
William Harris Investors
Illinois
$8.04M -$102K -25,000 -1%
Allianz Asset Management
10
Allianz Asset Management
Germany
$7.63M +$789K +193,528 +13%
Northern Trust
11
Northern Trust
Illinois
$7.16M +$95.4K +23,424 +1%
TAM
12
THB Asset Management
Connecticut
$3.94M -$958K -235,170 -21%
UBS AM
13
UBS AM
Illinois
$3.92M -$171K -42,000 -5%
ACM
14
Ashford Capital Management
Delaware
$3.8M +$2.73M +669,650 +373%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$3.68M +$367K +90,110 +12%
BC
16
Broadfin Capital
New York
$3.58M +$3.26M +800,000 New
Geode Capital Management
17
Geode Capital Management
Massachusetts
$2.79M +$470K +115,240 +23%
HCM
18
Harvey Capital Management
Florida
$2.39M +$24.4K +6,000 +1%
PI
19
Putnam Investments
Massachusetts
$2.17M +$1.98M +485,095 New
TCIM
20
TIAA CREF Investment Management
New York
$2.04M – – –
Fidelity Investments
21
Fidelity Investments
Massachusetts
$1.84M -$328K -80,500 -16%
CCM
22
Coe Capital Management
Illinois
$1.73M +$1.58M +387,475 New
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$1.62M +$68.5K +16,821 +5%
AC
24
Avenir Corporation
Virginia
$1.51M +$243K +59,625 +21%
California Public Employees Retirement System
25
California Public Employees Retirement System
California
$1.5M -$17.5K -4,300 -1%
1
2 3 4 5

ATRS Hedge Fund Activity: Q4 2013 in Review

89 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q4 2013, worth a combined $223M — up 30% from $171M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of ATRS and 13 opened new positions — a net loss of 8 holders — while 24 trimmed existing stakes and 33 added.

The largest buyer was Millennium Management, adding an estimated $8.6M. The largest seller was THB Asset Management, cutting an estimated $958K.

  • 89 institutional investors held Antares Pharma, Inc. (ATRS) as of Q4 2013, down from 97 in Q3 2013.
  • Funds reported $223M of Antares Pharma, Inc. stock for Q4 2013, up 30% quarter-over-quarter.
  • 13 funds opened new Antares Pharma, Inc. positions in Q4 2013 and 21 closed out, a net change of -8 holders.
  • The largest Antares Pharma, Inc. buyer in Q4 2013 was Millennium Management, an estimated $8.6M added.
  • The largest Antares Pharma, Inc. seller in Q4 2013 was THB Asset Management, an estimated $958K sold.

Based on aggregated 13F filings for Q4 2013.